EYLEA 40 mg/mL
aflibercept · INJECTION, SOLUTION · Regeneron Pharmaceuticals, Inc.
No Recall History
Plain English
EYLEA is a injection, solution containing aflibercept at 40 mg/mL, taken intravitreal. Manufactured by Regeneron Pharmaceuticals, Inc..
Key Facts
- Brand Name
- EYLEA
- Generic Name
- aflibercept
- NDC Code (Product)
61755-005- Manufacturer
- Regeneron Pharmaceuticals, Inc.
- Strength
- 40 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVITREAL
- Marketing Status
- Application #
- BLA125387
- Drug Class
- Vascular Endothelial Growth Factor Inhibitor [EPC]
- Marketing Start
- 11/21/2011
Recall History
No Recall HistoryFrequently Asked Questions
What is EYLEA used for?
EYLEA contains aflibercept. It is a injection, solution taken intravitreal. Consult your doctor for specific uses.
Is EYLEA a controlled substance?
EYLEA is not classified as a controlled substance by the DEA.
What is the generic name for EYLEA?
The generic name for EYLEA is aflibercept. There are 5 other brand versions of aflibercept.
What is the NDC code for EYLEA 40 mg/mL?
The NDC (National Drug Code) for EYLEA 40 mg/mL is 61755-005, listed by Regeneron Pharmaceuticals, Inc..